Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Provectus Pharmaceutical, Inc.
(OP:
PVCT
)
0.6810
USD
+0.0210 (+3.18%)
Official Closing Price
/ Updated:
5:20 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
70,796
Open
0.6700
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.6600
Today's Range
0.6500 - 0.7000
52wk Range
0.5500 - 0.8800
Shares Outstanding
126,397,398
Dividend Yield
N/A
Top News
More News
Provectus Updates Shareholders in Its Annual CEO Letter
May 13, 2013
from
Business Wire News Releases
Mentor Capital Cancer Immunotherapy Index Gains 28% During First Quarter of 2013
May 02, 2013
from
Business Wire News Releases
More News
Read More
PV-10 Data Presented by Moffitt Cancer Center Researchers Examines Induction of Systemic Immune Response in Multiple Tumor Types
April 10, 2013
from
Business Wire News Releases
Provectus Presents Data on PV-10 Combination Therapy at American Association of Cancer Research Annual Meeting
April 10, 2013
from
Business Wire News Releases
PV-10 Immunology Data Presented by Moffit Cancer Center Researchers at the American Association for Cancer Research Annual Meeting
April 08, 2013
from
Business Wire News Releases
BUYINS.NET Issues Provectus Pharmaceuticals SqueezeTrigger Report
April 01, 2013
from
GlobeNewswire News Releases
Immunology Data on PV-10 to Be Presented at the American Association for Cancer Research Annual Meeting
March 21, 2013
from
Business Wire News Releases
Data on Provectus's PV-10 to Be Presented at the HemOnc Today – Melanoma and Cutaneous Malignancies Conference on March 22, 2013
March 20, 2013
from
Business Wire News Releases
Provectus Pharmaceuticals Shares Are Trading on the OTCQB
January 25, 2013
from
Business Wire News Releases
Provectus Pharmaceuticals Launches Free Mobile Investor Relations Application
January 24, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here